Suppr超能文献

[高危非小细胞肺癌患者肺叶下切除的手术结果]

[Surgical Outcome of Sublobar Resection in High-risk Patients with Non-small Cell Lung Cancer].

作者信息

Nitanda Hiroyuki, Taguchi Ryo, Yanagihara Akitoshi, Sakaguchi Hirozo, Ishida Hironori, Kaneko Koichi

机构信息

Department of General Thoracic Surgery, Saitama Medical University International Medical Center, Hidaka, Japan.

出版信息

Kyobu Geka. 2019 Jan;72(1):17-22.

Abstract

OBJECTIVES

Pulmonary lobectomy is the standard surgical procedure for resectable non-small cell lung cancer (NSCLC), while sublobar resection is an important surgical alternative for high-risk patients with comorbidities. We evaluated the treatment outcome and prognostic factors of sublobar resection in high-risk patients with NSCLC.

METHODS

Eighty three high-risk patients who underwent compromised sublobar resection for clinical-N0 NSCLC with a solid appearance were retrospectively reviewed. A total of 47 wedge resections and 36 segmentectomies performed.

RESULTS

Poor pulmonary function and synchronous or metachronous multiple lung cancer were found in 56.7% and 20.5% of patients respectively, all requiring sublobar resection. There were 21 instances of tumor recurrence and 24 deaths during a mean follow-up of 1,500 days. There was no local recurrence in the segmentectomy group. The 3-year recurrence free survival (RFS) and overall survival (OS) were 72.6% and 73.8% respectively. A multivariate analysis indicated that resection type and lymphatic invasion were independent prognostic factors for RFS. In the wedge resection group, a ratio of surgical margin to clinical tumor size greater than 1 (MT ratio≥1) was an independent prognostic factor for RFS( 87.1%,p=0.001).

CONCLUSION

Segmentectomy leads to a favorable prognosis. MT ratio was independently associated with a longer RFS in the wedge resection group.

摘要

目的

肺叶切除术是可切除非小细胞肺癌(NSCLC)的标准手术方式,而亚肺叶切除术是合并症高危患者的重要手术替代方案。我们评估了NSCLC高危患者亚肺叶切除术的治疗效果和预后因素。

方法

回顾性分析83例因临床N0期实性外观NSCLC接受亚肺叶切除术的高危患者。共进行了47例楔形切除术和36例肺段切除术。

结果

分别有56.7%和20.5%的患者存在肺功能差以及同步或异时性多发肺癌,均需行亚肺叶切除术。在平均1500天的随访期间,有21例肿瘤复发和24例死亡。肺段切除术组无局部复发。3年无复发生存率(RFS)和总生存率(OS)分别为72.6%和73.8%。多因素分析表明,切除类型和淋巴侵犯是RFS的独立预后因素。在楔形切除术组中,手术切缘与临床肿瘤大小之比大于1(MT比≥1)是RFS的独立预后因素(87.1%,p=0.001)。

结论

肺段切除术预后良好。在楔形切除术组中,MT比与更长的RFS独立相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验